NewsGood News For CBD Industry After France’s Highest Court...

Good News For CBD Industry After France’s Highest Court Suspends Government Ban On Flowers

-

THE French CBD industry is celebrating after Government efforts to outlaw the sale of CBD flowers were suspended by the country’s highest court.

With flower accounting for almost three-quarters of sales this looks set to free the French CBD industry which believes it has the potential to surpass sales of €1bn within a few years.

The Government ban was announced on New Year’s Eve and within 24 hours a legal challenge was launched to have the decree dismissed.

On Friday, January 14, France’s highest court – the Council of State led by Judge Mrs Von Coester – listened to arguments from the industry through Hemp Professional Syndicate (SPC) and the Union of CBD Professionals (UPCBD).

‘Disproportionate Measure’

They asked the court to annul the government decision arguing it created an ‘economic emergency’ with many of the hundreds of CBD stores saying almost three-quarters of their income is derived from flower sales.

Yesterday, January 24, the court temporarily suspended the ban, with a statement saying: “The judge in chambers of the Council of State considers that there is a serious doubt about the legality of this general and absolute prohibition measure because of its disproportionate nature. 

“Indeed, it does not appear, at the end of the contradictory investigation and the exchanges which took place during the public hearing, that the flowers and leaves of cannabis sativa L. whose THC content is less than 0.3 % would present a degree of harmfulness to health justifying a total and absolute prohibition measure.” 

It concluded: “While waiting for the Council of State to rule definitively on the merits of the legality of the contested decree, the judge in chambers temporarily suspends the contested ban.” 

Preserves The Industry

Whilst the ruling is provisional and based on a ‘disproportionate’ act by the Government the court sill has to rule on the substance of the decree.

It has nevertheless been warmly received by the industry which believes it indicates a favourable attitude of the court in the case.

Writing on Twitter Yann Bisiou, a specialist in drug law, and legal consultant to the UPCBD, said: “A very nice decision that preserves the sector by allowing the cultivation of #cannabis light AND the marketing of the #CBD flowers and derivatives.”

He had earlier recounted how the UPCBD executives ‘worked on New Year’s Eve and lodged its appeal with the Council of State on January 1.

Speaking at the January 14, court hearing Aurélien Delecroix, of the SPC, told the court the industry’s currently valued at up to €400m with the potential to reach €1bn ‘in a mature market’.

Representing the Government at that hearing was the MILDECA, the Ministry of Health, which argued French law only allows for the sale of CBD extracts, whilst contending that CBD is psychoactive.

Further objections included arguments that as CBD flower is often smoked and could be mistaken for THC flowers creating problems of ‘public order’. 

KanaVape Precedent

The latest court case for the French CBD industry chimes with the KanaVape case which rumbled on for six years before being determined in the industry’s favour.

This had seen the French government argue that CBD is a narcotic only for the European Court of Justice (ECJ) to overturn this decision and rule CBD is not narcotic.

This opened the doors for the French industry to import and sell product from across the European Union under the free movement of goods rules which apply to the 28 member states.

As for what happens next? With an Election looming and President Macron wishing to remain a tough stance on drugs there may well be further political manoeuvres, although the authorities can only challenge the ECJ decision if they prove that CBD is not safe and can be viewed a narcotic.

Not The End Of The Road

Benjamin-Alexandre Jeanroy, of Paris-based cannabis consultancy Augur Associates, said: “This result is great news for all businesses that faced having their livelihoods taken from them by the government actions. But it’s in no way the end of the road.

“We will have to see how things unfold but I believe the Government will look for another baseless argument. As long as the government wishes to show it is ‘tough’ on drugs” – whatever that means – we can throw out any rational, data, or even legal argument, it won’t make them change their position. Not during an election campaign.”

The December 31 ban on flower sales was accompanied by two pieces of positive news with French farmers now able to extract CBD from the whole plant, and the permitted THC content rising from 0.2% to 0.3%.

Peter
Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

Poko Innovations, Inc. Receives Validation And Authorization To Sell 44 Items In The UK

POKO Innovations an award-winning UK-based collection of CBD-focused companies that bring innovative, inspiring solutions to the CBD industry through...

Intercure Posts More Record Results But Says It ‘Could Do So Much More’ If It Had More Supply

INTERCURE has released another set of ‘all time record quarterly’ results, seeing both revenues and profits skyrocket year-on-year.  Despite its...

Stenocare Delivers First Product Batch To The Danish Market

STENOCARE delivers the first product batch of their THC Oil to the Danish market. This means that the product is...

Chill Brands Targets Near £4m Capital Raise To Fund Fresh Strategy & £1.3m Chill.com Domain

CHILL Brands’ shareholders have voted in favour of plans for a new £3.5m fundraise alongside a separate £484,000 open...

Cellular Goods Makes More Major Changes To Board In First Update Since Ingestibles Were Pulled (UPDATED)

Cellular Goods has released its first significant update since announcing that its ingestibles products were not legally allowed to...

European Cannabis Stocks Review: Akanda Dives Over 80% & Celadon Suffers After Reporting Huge Rise In Losses

This week was another difficult week for London Stock Exchange (LSE) listed cannabis companies, with every one of BusinessCann's...

Must read

Intercure Posts More Record Results But Says It ‘Could Do So Much More’ If It Had More Supply

INTERCURE has released another set of ‘all time record...

Chill Brands Targets Near £4m Capital Raise To Fund Fresh Strategy & £1.3m Chill.com Domain

CHILL Brands’ shareholders have voted in favour of plans...

You might also likeRELATED
Recommended to you